1h Free Analyst Time
The recombinant proteins market is forecasted to grow by USD 899.1 million during 2024-2029, accelerating at a CAGR of 10.7% during the forecast period. The report on the recombinant proteins market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in chronic diseases, rising inclination toward biologics and biosimilars, and technological advancements in production of recombinant proteins.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The recombinant proteins market is segmented as below:
By Application
- Biotechnology research
- Drug discovery and development
- Biopharmaceutical production
- Others
By End-user
- Pharma and biotechnology companies
- Academic and research institutes
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the recombinant proteins market covers the following areas:
- Recombinant Proteins Market sizing
- Recombinant Proteins Market forecast
- Recombinant Proteins Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global recombinant proteins market: Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Bio Techne Corp., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., Grifols SA, Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi SA, Sino Biological Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in collaborations and strategic alliances by companies."
According to the report, one of the major drivers for this market is the increase in chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abcam plc
- Airway Therapeutics Inc.
- Amgen Inc.
- Aviva Systems Biology Corp.
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- BPS Bioscience Inc.
- Elabscience Biotechnology Inc.
- Enzo Biochem Inc.
- GenScript Biotech Corp.
- Grifols SA
- Merck KGaA
- Novartis AG
- Novo Nordisk AS
- OriGene Technologies Inc.
- Prospec Tany Technogene Ltd.
- Proteintech Group Inc.
- Sanofi SA
- Sino Biological Inc.
- Thermo Fisher Scientific Inc.
